Related Experiment Video
Updated: Apr 17, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Rare childhood cancers--an increasing entity requiring the need for global consensus and collaboration
Rishi S Kotecha1,2,3, Ursula R Kees3, Catherine H Cole1,2
1Department of Haematology and Oncology, Princess Margaret Hospital for Children, GPO Box D184, Perth, Western Australia, 6840, Australia.
Abstract:
Rare childhood cancers have not benefited to the same extent from the gains that have been made for their frequently occurring counterparts. In recent years, this gap has been recognized and a number of vehicles now exist to improve outcome, including rare tumor groups, disease-specific registries, and clinics. The multitude of approaches has allowed significant progress, however, this framework is limited by patient number and is not inclusive for every type of rare childhood cancer. These shortcomings can be overcome by a single global unified approach to the study of rare childhood tumors.
Insights
Rare childhood cancers lag behind common cancers in treatment advances. A unified global approach is needed to overcome limitations in current rare tumor research and improve outcomes for all children.
Area of Science:
- Pediatric Oncology
- Cancer Research
Background:
- Rare childhood cancers have seen less progress compared to common cancers.
- Existing initiatives like tumor groups and registries have improved outcomes but face limitations.
- Patient numbers and inclusivity remain challenges for current rare cancer research frameworks.
Purpose of the Study:
- To highlight the need for a more comprehensive approach to studying rare childhood tumors.
- To address the limitations of current fragmented research efforts in pediatric oncology.
Main Methods:
- Review of existing strategies for rare childhood cancer research.
- Analysis of the shortcomings of current patient number and inclusivity limitations.
Main Results:
- Current approaches, while beneficial, are insufficient for all rare childhood cancers.
- Fragmented efforts limit the potential for significant breakthroughs.
Conclusions:
- A single, global, unified approach is essential for advancing the study and treatment of rare childhood tumors.
- Overcoming current limitations requires international collaboration and a consolidated research strategy.
Related Concept Videos
Treatment Resistent Cancers
Treatment Resistant Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell

